Most cited papers from Michigan Center for Translational Pathology
What are the most cited papers from Michigan Center for Translational Pathology?
The most cited paper from Michigan Center for Translational Pathology is "Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018" (Lorenzo Galluzzi et al., 2018), with 6,760 citations. Next come "Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma" (4,157) and "The repertoire of mutational signatures in human cancer" (3,854).
Showing 50 of 60 papers. Every paper with more than 919 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 Lorenzo Galluzzi et al. · Cell Death and Differentiation | 23 Jan 2018 | 6,760 |
| 2 | Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma Stephen J. Schuster et al. · New England Journal of Medicine | Dec 2018 | 4,157 |
| 3 | The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature | 5 Feb 2020 | 3,854 |
| 4 | Integrative Clinical Genomics of Advanced Prostate Cancer Dan R. Robinson et al. · Cell | May 2015 | 3,727 |
| 5 | Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer Daniel Peter Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine | 6 Oct 2004 | 3,706 |
| 6 | Oncogenic Signaling Pathways in The Cancer Genome Atlas Francisco Sánchez-Vega et al. · Cell | Apr 2018 | 3,452 |
| 7 | Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature | 5 Feb 2020 | 3,360 |
| 8 | A reference panel of 64,976 haplotypes for genotype imputation Shane McCarthy et al. · Nature Genetics | 22 Aug 2016 | 3,318 |
| 9 | CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy Weimin Wang et al. · Nature | May 2019 | 2,952 |
| 10 | The landscape of long noncoding RNAs in the human transcriptome Matthew K. Iyer, Yashar S. Niknafs, Rohit Malik et al. · Nature Genetics | 19 Jan 2015 | 2,921 |
| 11 | Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Christopher J. Sweeney, Yu‐Hui Chen, Michael Anthony Carducci et al. · New England Journal of Medicine | 5 Aug 2015 | 2,915 |
| 12 | ProteomeXchange provides globally coordinated proteomics data submission and dissemination Juan Antonio Vizcaíno et al. · Nature Biotechnology | Mar 2014 | 2,912 |
| 13 | The polycomb group protein EZH2 is involved in progression of prostate cancer Sooryanarayana Varambally, Saravana Mohan Dhanasekaran, Ming Zhou et al. · Nature | Oct 2002 | 2,740 |
| 14 | UALCAN: An update to the integrated cancer data analysis platform Darshan Shimoga Chandrashekar, Santhosh Kumar Karthikeyan, Praveen Kumar Korla et al. · Neoplasia | 22 Jan 2022 | 2,635 |
| 15 | The mutational landscape of lethal castration-resistant prostate cancer Catherine S. Grasso et al. · Nature | 18 May 2012 | 2,622 |
| 16 | Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy Nisha Nagarsheth, Max S. Wicha, Weiping Zou · Nature reviews. Immunology | 30 May 2017 | 2,379 |
| 17 | Role of the gut microbiota in immunity and inflammatory disease Nobuhiko Kamada, Sang‐Uk Seo, Grace Chen et al. · Nature reviews. Immunology | 25 Apr 2013 | 2,285 |
| 18 | Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Arun Sreekumar et al. · Nature | Feb 2009 | 2,269 |
| 19 | K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter Raúl Muñoz-Planillo, Peter Kuffa, Giovanny J. Martínez-Colón et al. · Immunity | Jun 2013 | 2,200 |
| 20 | The Landscape of Circular RNA in Cancer Josh N. Vo, Marcin P. Cieslik, Yajia Zhang et al. · Cell | Feb 2019 | 2,070 |
| 21 | 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years Hongchao Pan, Richard G. Gray, Jeremy P. Braybrooke et al. · New England Journal of Medicine | 8 Nov 2017 | 1,883 |
| 22 | Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan Stuart Coates et al. · Annals of Oncology | 4 May 2015 | 1,865 |
| 23 | The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Luigi Franchi, Tatjana Eigenbrod, Raúl Muñoz-Planillo et al. · Nature Immunology | 17 Feb 2009 | 1,863 |
| 24 | The Emergence of lncRNAs in Cancer Biology John R. Prensner, Arul M. Chinnaiyan · Cancer Discovery | Oct 2011 | 1,825 |
| 25 | Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract Koichi S. Kobayashi, Mathias Chamaillard, Yasunori Ogura et al. · Science | 3 Feb 2005 | 1,777 |
| 26 | Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease Joseph M. Pickard, Melody Y. Zeng, Roberta Caruso et al. · Immunological Reviews | 30 Aug 2017 | 1,753 |
| 27 | The Role of Non-coding RNAs in Oncology Frank John Slack, Arul M. Chinnaiyan · Cell | Nov 2019 | 1,746 |
| 28 | Delineation of prognostic biomarkers in prostate cancer Saravana Mohan Dhanasekaran, Terrence R. Barrette, Debashis Ghosh et al. · Nature | Aug 2001 | 1,691 |
| 29 | Control of pathogens and pathobionts by the gut microbiota Nobuhiko Kamada, Grace Chen, Naohiro Inohara et al. · Nature Immunology | 18 Jun 2013 | 1,657 |
| 30 | Initial genome sequencing and analysis of multiple myeloma Michael A. Chapman et al. · Nature | Mar 2011 | 1,472 |
| 31 | Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Kathy S. Albain et al. · The Lancet Oncology | 12 Dec 2009 | 1,418 |
| 32 | Cancer Stem Cells: An Old Idea—A Paradigm Shift Max S. Wicha, Suling Liu, Gabriela Dontu · Cancer Research | 15 Feb 2006 | 1,382 |
| 33 | Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB Yasunori Ogura, Naohiro Inohara, Adalberto Benito et al. · Journal of Biological Chemistry | Feb 2001 | 1,377 |
| 34 | Regional Nodal Irradiation in Early-Stage Breast Cancer Timothy Joseph Whelan et al. · New England Journal of Medicine | 22 Jul 2015 | 1,324 |
| 35 | De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Giuseppe Curigliano et al. · Annals of Oncology | 11 Jun 2017 | 1,263 |
| 36 | Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study Kerby Shedden et al. · Nature Medicine | 20 Jul 2008 | 1,253 |
| 37 | Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy Dongjun Peng, Ilona Kryczek, Nisha Nagarsheth et al. · Nature | 26 Oct 2015 | 1,219 |
| 38 | Further development and validation of empirical scoring functions for structure-based binding affinity prediction Renxiao Wang, Luhua Lai, Shaomeng Wang · Journal of Computer-Aided Molecular Design | 2002 | 1,205 |
| 39 | Activating ESR1 mutations in hormone-resistant metastatic breast cancer Dan R. Robinson et al. · Nature Genetics | 3 Nov 2013 | 1,177 |
| 40 | Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3 Thirumala‐Devi Kanneganti, Nesrin Özören, Mathilde Body–Malapel et al. · Nature | 11 Jan 2006 | 1,150 |
| 41 | The evolutionary history of 2,658 cancers Moritz Gerstung et al. · Nature | 5 Feb 2020 | 1,149 |
| 42 | Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer Massimo Cristofanilli, Daniel F.C. Hayes, George Thomas Budd et al. · Journal of Clinical Oncology | 26 Feb 2005 | 1,139 |
| 43 | Microsatellite instability in colorectal cancer—the stable evidence Eduardo Vilar, Stephen B. Gruber · Nature Reviews Clinical Oncology | 9 Feb 2010 | 1,102 |
| 44 | Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11 Xueting Lang et al. · Cancer Discovery | 25 Sep 2019 | 1,094 |
| 45 | Diabetes: a 21st century challenge Paul Zimmet, Dianna J. Magliano, William H. Herman et al. · The Lancet Diabetes & Endocrinology | 3 Dec 2013 | 1,094 |
| 46 | Intracellular NOD-like Receptors in Host Defense and Disease Thirumala‐Devi Kanneganti, Mohamed Lamkanfi, Gabriel Núñez · Immunity | Oct 2007 | 1,069 |
| 47 | Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer Sooryanarayana Varambally, Qi Ling Cao, Ram Shankar Mani et al. · Science | 13 Nov 2008 | 1,060 |
| 48 | Caspases: the proteases of the apoptotic pathway Gabriel Núñez, Mary Benedict, Yuanmimg Hu et al. · Oncogene | 24 Dec 1998 | 1,051 |
| 49 | Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression John R. Prensner, Matthew K. Iyer, O. Alejandro Balbin et al. · Nature Biotechnology | 31 Jul 2011 | 1,047 |
| 50 | Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis Emina H. Huang, Mark J. Hynes, Tao Zhang et al. · Cancer Research | Apr 2009 | 1,043 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.